dronabinol has been researched along with Agitation, Psychomotor in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bagetta, G; Boccella, S; Corasaniti, MT; Guida, F; Luongo, L; Maione, S; Nicotera, P; Scuteri, D; Tonin, P | 1 |
| Andreazza, AC; Black, SE; Gallagher, D; Herrmann, N; Kiss, A; Lanctôt, KL; Ruthirakuhan, M; Verhoeff, NPLG | 2 |
| Ahl, B; Anghelescu, IG; Wilhelm, R | 1 |
| Amjad, H; Burhanullah, MH; Forester, BP; Monette, PJ; Outen, JD; Rosenberg, PB; Vandrey, R | 1 |
| Carbonaro, S; DeFrancisco, DR; Galynker, II; Hurd, YL; Mann, CL; Parvez, L; Perkel, CA; Spriggs, S | 1 |
| Ellison, JM; Forester, BP; Harper, DG; Stolyar, A; Woodward, MR | 1 |
| Ahmed, AI; Feuth, T; Kramers, C; Olde Rikkert, MG; Rosenberg, PB; van den Elsen, GA; van der Marck, MA; Verkes, RJ | 1 |
| Mills, B; Nugent, K; Yepes, A | 1 |
| Homan, P; Schüpbach, B; Seifritz, E; Strik, W; Walther, S | 1 |
| Eichmann, U; Kunz, D; Mahlberg, R; Walther, S | 1 |
| Mahlberg, R; Walther, S | 1 |
| Passmore, MJ | 1 |
| Budney, AJ; Hughes, JR; Moore, BA; Novy, PL | 1 |
2 review(s) available for dronabinol and Agitation, Psychomotor
| Article | Year |
|---|---|
Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation.
Topics: Aged; Alzheimer Disease; Biomarkers; Cognition; Cytokines; Dronabinol; Female; Humans; Male; Oxidative Stress; Psychomotor Agitation | 2020 |
Synthetic Cannabinoids.
Topics: Acute Kidney Injury; Cannabinoid Receptor Agonists; Cannabinoids; Chest Pain; Designer Drugs; Dronabinol; Hallucinations; Humans; Hypertension; Irritable Mood; Psychomotor Agitation; Substance-Related Disorders; Tachycardia; Vertigo | 2015 |
6 trial(s) available for dronabinol and Agitation, Psychomotor
| Article | Year |
|---|---|
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol.
Topics: Aged; Cannabidiol; Chronic Pain; Dementia; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Oral Sprays; Psychomotor Agitation; Randomized Controlled Trials as Topic | 2022 |
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Aggression; Cannabinoid Receptor Agonists; Dementia; Double-Blind Method; Dronabinol; Humans; Male; Psychomotor Agitation; Quality of Life; Treatment Outcome | 2015 |
Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia.
Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Cross-Over Studies; Dementia; Dronabinol; Humans; Male; Psychomotor Agitation | 2011 |
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Dronabinol; Electroencephalography; Female; Hallucinogens; Humans; Male; Motor Activity; Pilot Projects; Psychomotor Agitation; Sleep Wake Disorders | 2006 |
Actigraphy in agitated patients with dementia. Monitoring treatment outcomes.
Topics: Aged; Aged, 80 and over; Dementia; Dronabinol; Female; Humans; Male; Melatonin; Middle Aged; Monitoring, Ambulatory; Motor Activity; Outcome Assessment, Health Care; Psychomotor Agitation; Psychotropic Drugs; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
Marijuana abstinence effects in marijuana smokers maintained in their home environment.
Topics: Adolescent; Adult; Affective Symptoms; Aggression; Ambulatory Care; Behavior, Addictive; Creatinine; Dronabinol; Feeding and Eating Disorders; Female; Humans; Male; Marijuana Abuse; Middle Aged; Personality Inventory; Psychomotor Agitation; Severity of Illness Index; Sleep Wake Disorders; Substance Abuse Detection; Substance Withdrawal Syndrome; Weight Loss | 2001 |
6 other study(ies) available for dronabinol and Agitation, Psychomotor
| Article | Year |
|---|---|
Dextrometorphan-Paroxetine, But Not Dronabinol, Effective for Treatment-Resistant Aggression and Agitation in an Elderly Patient With Lewy Body Dementia.
Topics: Aged; Aggression; Cannabinoid Receptor Agonists; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dronabinol; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Lewy Body Disease; Male; Paroxetine; Psychomotor Agitation | 2017 |
Tetrahydrocannabinol Has Potential for Treating Agitation in Alzheimer's Disease.
Topics: Aggression; Alzheimer Disease; Dronabinol; Humans; Psychomotor Agitation | 2019 |
The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
Topics: Adult; Cannabinoids; Dronabinol; Female; Humans; Inpatients; Male; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotropic Drugs; Risk Factors; Sex Factors; Substance Abuse Detection; United States | 2019 |
24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone.
Topics: Aged, 80 and over; Alzheimer Disease; Anti-Anxiety Agents; Cross-Sectional Studies; Dronabinol; Female; Humans; Hydroxycholesterols; Longitudinal Studies; Male; Psychomotor Agitation; Treatment Outcome | 2019 |
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms.
Topics: Aggression; Anorexia; Antidepressive Agents; Antipsychotic Agents; Cannabinoid Receptor Agonists; Cholinesterase Inhibitors; Cohort Studies; Dementia; Dronabinol; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Mental Disorders; Psychomotor Agitation; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
The cannabinoid receptor agonist nabilone for the treatment of dementia-related agitation.
Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Dronabinol; Humans; Male; Psychomotor Agitation; Treatment Outcome | 2008 |